IBEX Technologies Granted Human Kallikrein 6 (hK6) Patent

MONTREAL, QUEBEC--(MARKET WIRE)--Aug 16, 2007 -- IBEX Technologies Inc. (Toronto:IBT.TO - News) announced that the Company's patent for the use of hK6 in ovarian cancer tests has been granted in Europe.